RankAlpha logo
Back to Rankings

ESPR

Esperion TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
The primary-source case is mostly deal-based rather than standalone-growth based: the signed merger sets a near-term value floor at $3.16 cash per share, the CVR preserves some upside optionality, Q1 2026 revenue rose to $80.1 million from $65.0 million, and operating loss narrowed materially year over year [#8-K-2026-05-01] [#10-Q-2026-05-08].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.3.
What can break
Corstasis adds integration and milestone-payment complexity; Enbumyst may not scale enough to offset acquisition cost and contingent obligations [#10-Q-2026-05-08].
Momentum
94
Value
41
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.18 · Bull $3.55 · Bear $2.25
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-05-27 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-14 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $6.83
Why
Momentum94 · Δ7d -1.3
Value41 · Δ7d +0.1
Sentiment46 · Δ7d +3.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
94
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.3
Δ21d
+65.8
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
46
33% active weight
Current posture
7d trendImproving
Δ7d
+3.3
Δ21d
-52.2
Why this grade

Composite grade B. Momentum 94.1 / Value 41.1 / Sentiment 46.5

Fundamentals (TTM)
As of 2026-05-27
Market Cap
$805.76M
Beta
1.09
Shares Out
239.06M
P/E (TTM) · Derived
-12.0
P/S (TTM)
3.00
P/FCF (TTM) · Derived
-7.14
Rev YoY
+69.1%
EPS YoY
-3.1%
Gross Margin
+58.2%
Op Margin
-10.2%
Net Debt
$441.14M
Current Ratio
1.00
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology